Cover Image

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?

Saved in:

Bibliographic Details
Main Authors:	Yufeng Xi (Author), Yujia Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drugging the Epigenome: Overcoming Resistance to Targeted and Immunotherapies in Melanoma
by: Ailish Hanly, et al.
Published: (2022)

LINC01001 Promotes Progression of Crizotinib-Resistant NSCLC by Modulating IGF2BP2/MYC Axis
by: Meiling Zhang, et al.
Published: (2021)

Zmiany w stężeniach insulinopodobnych czynników wzrostu IGF-1 i IGF-2 i białek wiążących BP-2 i BP-3 w czasie leczenia ostrej białaczki limfoblastycznej
by: Maryna Krawczuk-Rybak, et al.
Published: (2004)

IGF2BP3 promotes glutamine metabolism of endometriosis by interacting with UCA1 to enhances the mRNA stability of GLS1
by: Honglin Wang, et al.
Published: (2024)

Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
by: Yufeng Xi, et al.
Published: (2022)

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in hematological diseases
by: Shuangping Ma, et al.
Published: (2024)

Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL
by: Yuxin Hong, et al.
Published: (2024)

METTL3 and IGF2BP1-mediated m6A modification of ZHX2 promotes tumor property of renal cell carcinoma
by: Bangming Xiao, et al.
Published: (2024)

Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting
by: Minglu Zhou, et al.
Published: (2019)

IGF2BP3 (IMP3) expression in angiosarcoma, epithelioid hemangioendothelioma, and benign vascular lesions
by: Misuzu Okabayshi, et al.
Published: (2020)

miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K/Akt and p53 in Immune Thrombocytopenia
by: Yanan Wang, et al.
Published: (2020)

Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
by: Martina Godel, et al.
Published: (2021)

RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression
by: Laura Regué, et al.
Published: (2021)

Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis
by: Ying Feng, et al.
Published: (2023)

Differential expression and clinical significance of IGF2BP3 in peritoneal dialysate of patients with varying duration of peritoneal dialysis
by: Xiaoqi Shao, et al.
Published: (2024)

Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis
by: Yuhang Xiao, et al.
Published: (2022)

Targeting And‐1 to overcome radiation resistance in colorectal cancer
by: Daniel R. Principe
Published: (2022)

RESISTANCE TO TARGETED THERAPIES IN MELANOMA: NEW INSIGHTS
by: Giuseppe Palmieri, et al.
Published: (2013)

The new concepts on overcoming drug resistance in lung cancer
by: Zhang W, et al.
Published: (2014)

TMAO Promotes NLRP3 Inflammasome Activation of Microglia Aggravating Neurological Injury in Ischemic Stroke Through FTO/IGF2BP2
by: Ge P, et al.
Published: (2023)

SOX4 Mediates BRAF Inhibitor Resistance in Melanoma through Regulation of IGF-1R Signaling: In Vitro Study
by: Xiao Liu, et al.
Published: (2020)

Suppression of IGF1R in Melanoma Cells by an Adenovirus-Mediated One-Step Knockdown System
by: Haoran Xin, et al.
Published: (2018)

Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
by: Andrea Cunha, et al.
Published: (2023)

Blocking the IGF2BP1-promoted glucose metabolism of colon cancer cells via direct de-stabilizing mRNA of the LDHA enhances anticancer effects
by: Xiang-liang Zhang, et al.
Published: (2021)

Implication of genetic variants near <it>SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2</it>, <it>KCNQ1</it>, and <it>WFS1 </it>in Type 2 Diabetes in a Chinese population
by: Zhou Xianghai, et al.
Published: (2010)

Oncogenic Role of Long Noncoding RNAMALAT1 in Thyroid Cancer Progression through Regulation of the miR-204/IGF2BP2/m6A-MYC Signaling
by: Mao Ye, et al.
Published: (2021)

Targeting Ubiquitin-Specific Protease 7 (USP7) in Cancer: A New Insight to Overcome Drug Resistance
by: Jiabin Lu, et al.
Published: (2021)

Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL
by: Ting Yu, et al.
Published: (2021)

The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells
by: Dan-dan Xu, et al.
Published: (2018)

New approaches to overcome transport related drug resistance in trypanosomatid parasites
by: Jose A Garcia-Salcedo, et al.
Published: (2016)

Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap
by: Jakub Szymczyk, et al.
Published: (2024)

Strategies to overcome drug resistance using SHP2 inhibitors
by: Meng Liu, et al.
Published: (2021)

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
by: Marie Angèle Cucci, et al.
Published: (2023)

CircNRIP1 promotes proliferation, migration and phenotypic switch of Ang II-induced HA-VSMCs by increasing CXCL5 mRNA stability via recruiting IGF2BP1
by: Xianzhao Cao, et al.
Published: (2024)

Nanomedicines for Overcoming Cancer Drug Resistance
by: Tingting Hu, et al.
Published: (2022)

Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
by: Xue Han, et al.
Published: (2019)

Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
by: Lei Wang, et al.
Published: (2022)

Targeting O‐GlcNAcylation to overcome resistance to radiotherapy
by: Joanna Przybyl
Published: (2022)

Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
by: Pópulo H, et al.
Published: (2021)

EphB4 inhibitor overcome the acquired resistance to cisplatin in melanomas xenograft model
by: Xiaokun Yang, et al.
Published: (2015)